BridgeBio Pharma Ownership | Who Owns BridgeBio Pharma?


OverviewForecastRevenueFinancialsChartTranscripts

BridgeBio Pharma Ownership Summary


BridgeBio Pharma is owned by 99.09% institutional investors, 4.77% insiders. Vanguard group is the largest institutional shareholder, holding 8.83% of BBIO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.83% of its assets in BridgeBio Pharma shares.

BBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBridgeBio Pharma99.09%4.77%-3.85%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group16.83M8.83%$874.26M
Viking global investors lp15.98M8.39%$829.89M
Blackrock funding, inc. /de14.41M7.56%$748.52M
Kohlberg kravis roberts13.26M6.96%$688.77M
Blackrock12.45M6.64%$315.31M
Farallon capital management8.19M4.30%$425.49M
Aisling capital management lp6.09M3.20%$316.29M
State street5.61M2.94%$291.19M
Janus henderson group4.91M2.60%$134.67M
Invesco3.93M2.06%$204.05M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aisling capital management lp6.09M69.29%$316.29M
Kohlberg kravis roberts13.26M11.54%$688.77M
Boone capital management460.28K7.84%$23.91M
Cutter capital management, lp560.34K6.30%$15.38M
Frazier life sciences management3.85M5.98%$199.73M
Catalio capital management, lp622.73K5.98%$32.34M
Monashee investment management200.00K5.18%$10.39M
Cormorant asset management, lp1.40M5.02%$72.72M
First turn management589.73K4.60%$30.63M
Superstring capital management lp88.66K4.54%$4.60M

Top Buyers

HolderShares% AssetsChange
Blackrock12.45M0.01%1.98M
Hood river capital management1.24M0.76%1.24M
Invesco3.93M0.03%1.13M
Norges bank1.07M0.00%1.07M
T. rowe price investment management1.05M0.03%1.05M

Top Sellers

HolderShares% AssetsChange
Viking global investors lp15.98M2.16%-2.58M
Capital research global investors1.93M0.02%-2.06M
Woodline partners lp198.32K0.05%-1.51M
Perceptive advisors---1.22M
Hhlr advisors---1.02M

New Positions

HolderShares% AssetsChangeValue
Hood river capital management1.24M0.76%1.24M$64.59M
Norges bank1.07M0.00%1.07M$29.24M
T. rowe price investment management1.05M0.03%1.05M$54.63M
Polar capital981.06K0.25%981.06K$50.96M
Gw&k investment management598.24K0.27%598.24K$31.07M

Sold Out

HolderChange
Weiss asset management lp-1.00
Financial gravity asset management-3.00
Creekmur asset management-3.00
Twin peaks wealth advisors-6.00
Rakuten securities-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202539213.29%188,775,9601.99%991.05%22614.14%10932.93%
Mar 31, 202534412.05%185,144,5074.79%971.11%19624.05%825.13%
Dec 31, 20243048.57%172,882,4320.83%911.11%1556.90%781.30%
Sep 30, 2024278-2.11%171,231,529-1.98%901.05%147-3.29%742.78%
Jun 30, 20242841.43%174,683,4282.52%931.02%15211.76%72-15.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv5.40M2.83%-130.43K
Vanguard US Total Market Shares ETF4.53M2.38%3.92K
Vanguard Small Cap Index4.15M2.17%-28.15K
iShares Russell 2000 ETF3.77M1.97%-
SPDR® S&P Biotech ETF2.40M1.26%5.36K
Vanguard Small Cap Growth Index Inv2.34M1.22%-6.35K
American Funds SMALLCAP World A2.07M1.09%-596.87K
Janus Henderson Global Life Sciences1.62M0.85%573.25K
Janus Henderson Global Life Sciences D1.62M0.85%28.25K
Vanguard Institutional Extnd Mkt Idx Tr1.59M0.83%-695.01K

Recent Insider Transactions


DateNameRoleActivityValue
Nov 12, 2025Valantine Hannah-Sell$1.68M
Nov 06, 2025Kumar Neil Chief Executive OfficerSell$6.44K
Nov 06, 2025Kumar Neil Chief Executive OfficerSell$465.42K
Nov 06, 2025Kumar Neil Chief Executive OfficerSell$791.17K
Nov 07, 2025Kumar Neil Chief Executive OfficerSell$763.76K

Insider Transactions Trends


DateBuySell
2025 Q4-26
2025 Q3-35
2025 Q2-16
2025 Q1-15
2024 Q4-3

BBIO Ownership FAQ


Who Owns BridgeBio Pharma?

BridgeBio Pharma shareholders are primarily institutional investors at 99.09%, followed by 4.77% insiders and -3.86% retail investors. The average institutional ownership in BridgeBio Pharma's industry, Biotech Stocks , is 295.31%, which BridgeBio Pharma falls below.

Who owns the most shares of BridgeBio Pharma?

BridgeBio Pharma’s largest shareholders are Vanguard group (16.83M shares, 8.83%), Viking global investors lp (15.98M shares, 8.39%), and Blackrock funding, inc. /de (14.41M shares, 7.56%). Together, they hold 24.79% of BridgeBio Pharma’s total shares outstanding.

Does Blackrock own BridgeBio Pharma?

Yes, BlackRock owns 6.64% of BridgeBio Pharma, totaling 12.45M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 315.31M$. In the last quarter, BlackRock increased its holdings by 1.98M shares, a 18.93% change.

Who is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested?

Aisling capital management lp is BridgeBio Pharma’s biggest shareholder by percentage of total assets invested, with 69.29% of its assets in 6.09M BridgeBio Pharma shares, valued at 316.29M$.

Who is the top mutual fund holder of BridgeBio Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of BridgeBio Pharma shares, with 2.83% of its total shares outstanding invested in 5.4M BridgeBio Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools